Calidi Biotherapeutics, Inc.CLDINYSE
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank75
3Y CAGR-49.3%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-49.3%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 82.80% |
| 2023 | 42.14% |
| 2022 | -2633.90% |
| 2021 | 636.36% |
| 2020 | 0.00% |